Sandhya Chahal

Jind, HR 126102, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Development of a double-pharmacophore workflow for screening subtype-selective M3 muscarinic acetylcholine receptor antagonists.

Development of a double-pharmacophore workflow for screening subtype-selective M3 muscarinic acetylcholine receptor antagonists.

Journal: Molecular diversity

Published: April 13, 2026

Corrigendum to "Design and development of chromene-3-carboxylate derivatives as antidiabetic agents: Exploring the antidiabetic potential via dual inhibition of angiotensin II type 1 receptor and neprilysin enzyme" [Europ. J. Med. Chem. 293 (2025) 117705].

Corrigendum to "Design and development of chromene-3-carboxylate derivatives as antidiabetic agents: Exploring the antidiabetic potential via dual inhibition of angiotensin II type 1 receptor and neprilysin enzyme" [Europ. J. Med. Chem. 293 (2025) 117705].

Journal: European journal of medicinal chemistry

Published: June 17, 2025

Design and development of sulfenylated 5-aminopyrazoles as inhibitors of acetylcholinesterase and butyrylcholinesterase: exploring the implication for Aβ1-42 aggregation inhibition in Alzheimer's disease.

Design and development of sulfenylated 5-aminopyrazoles as inhibitors of acetylcholinesterase and butyrylcholinesterase: exploring the implication for Aβ1-42 aggregation inhibition in Alzheimer's disease.

Journal: RSC medicinal chemistry

Published: January 22, 2025

Design and development of chromene-3-carboxylate derivatives as antidiabetic agents: Exploring the antidiabetic potential via dual inhibition of angiotensin II type 1 receptor and neprilysin enzyme.

Design and development of chromene-3-carboxylate derivatives as antidiabetic agents: Exploring the antidiabetic potential via dual inhibition of angiotensin II type 1 receptor and neprilysin enzyme.

Journal: European journal of medicinal chemistry

Published: January 20, 2025

Novel C-4 sulfenylated pyrazoles as α-amylase inhibitors: Insights from in silico and in vitro studies.

Novel C-4 sulfenylated pyrazoles as α-amylase inhibitors: Insights from in silico and in vitro studies.

Journal: Bioorganic chemistry

Published: January 18, 2025

Multicomponent Synthesis of 2,4,5-Trisubstituted Thiazoles Using a Sustainable Carbonaceous Catalyst and Assessment of Its Herbicidal and Antibacterial Potential.

Multicomponent Synthesis of 2,4,5-Trisubstituted Thiazoles Using a Sustainable Carbonaceous Catalyst and Assessment of Its Herbicidal and Antibacterial Potential.

Journal: Journal of agricultural and food chemistry

Published: December 04, 2024

Naphthoquinone fused diazepines targeting hyperamylasemia: potential therapeutic agents for diabetes and cancer.

Naphthoquinone fused diazepines targeting hyperamylasemia: potential therapeutic agents for diabetes and cancer.

Journal: Future medicinal chemistry

Published: September 20, 2024

Diastereomeric pure pyrazolyl-indolyl dihydrofurans: Unveiling isomeric selectivity in antibacterial action via in vitro and in silico insights.

Diastereomeric pure pyrazolyl-indolyl dihydrofurans: Unveiling isomeric selectivity in antibacterial action via in vitro and in silico insights.

Journal: Bioorganic & medicinal chemistry letters

Published: July 31, 2024

Repurposing of USFDA-approved drugs to identify leads for inhibition of acetylcholinesterase enzyme: a plausible utility as an anti-Alzheimer agent.

Repurposing of USFDA-approved drugs to identify leads for inhibition of acetylcholinesterase enzyme: a plausible utility as an anti-Alzheimer agent.

Journal: RSC medicinal chemistry

Published: June 20, 2024

Pyrano[2,3-c]pyrazole fused spirooxindole-linked 1,2,3-triazoles as antioxidant agents: Exploring their utility in the development of antidiabetic drugs via inhibition of α-amylase and DPP4 activity.

Pyrano[2,3-c]pyrazole fused spirooxindole-linked 1,2,3-triazoles as antioxidant agents: Exploring their utility in the development of antidiabetic drugs via inhibition of α-amylase and DPP4 activity.

Journal: Bioorganic chemistry

Published: January 17, 2024

Pushing Boundaries: What's Next in Metal-Free C-H Functionalization for Sulfenylation?

Pushing Boundaries: What's Next in Metal-Free C-H Functionalization for Sulfenylation?

Journal: Topics in current chemistry (Cham)

Published: August 25, 2023

Electro-organic synthesis of C-5 sulfenylated amino uracils: Optimization and exploring topoisomerase-I based anti-cancer profile.

Electro-organic synthesis of C-5 sulfenylated amino uracils: Optimization and exploring topoisomerase-I based anti-cancer profile.

Journal: Bioorganic chemistry

Published: February 07, 2023

Showing 1-12 of 13

Last Updated: 09/26/2026